Clinical Trial Update: Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease

View source ↗

Summary

This completed AstraZeneca-sponsored clinical trial assessed symptom control and the impact on daily life in patients with gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Nexium (esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Status: COMPLETED